Showing results (1731-1740 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|April 12, 2024
Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task ForceAkshay Sharma, Agnieszka Czechowicz, Melissa Mavers, et al.
Transplantation and Cellular Therapy|January 24, 2024
A Positive Psychology Intervention for Caregivers of Hematopoietic Stem Cell Transplantation Survivors (PATH-C): Initial Testing and Single-Arm Pilot TrialHermioni L Amonoo, Michelle Guo, Annabella C Boardman, et al.
Transplantation and Cellular Therapy|January 23, 2024
Communication About Chimeric Antigen Receptor T-Cell (CAR-T) TherapyTejaswini Dhawale, P Connor Johnson, Kofi Boateng, et al.
Transplantation and Cellular Therapy|February 8, 2024
Comparison of Melphalan Dose in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation with Reduced-Intensity ConditioningShuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.
Transplantation and Cellular Therapy|February 6, 2024
A Day 14 Endpoint for Acute GVHD Clinical TrialsNikolaos Spyrou, Yu Akahoshi, Steven Kowalyk, et al.
Transplantation and Cellular Therapy|January 19, 2024
Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Preexisting DiabetesNahid Rashid, Ted Gooley, Michael Boeckh, et al.
Transplantation and Cellular Therapy|September 2, 2024
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary SyndromeAmrita Goyal, Daniel O'Leary, Bouthaina Dabaja, et al.
Transplantation and Cellular Therapy|September 2, 2024
Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White PatientsCarlos A Ortega Rios, Muna Qayed, Aaron M Etra, et al.
Transplantation and Cellular Therapy|August 24, 2024
Design and Development of a Multimodal Digital Intervention (SHIFT App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant (HSCT) SurvivorsRichard Newcomb, Lara Traeger, Bailey Jones, et al.
Transplantation and Cellular Therapy|September 14, 2024
Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell TransplantIbrahim N Muhsen, Kristen E Shaver, Tao Wang, et al.
Pageof 183